On June 17, 2026, PsiQuantum's Interim CEO Victor Peng stood on a 42-acre industrial site in Queensland, Australia, and broke ground on what the company claims will be the world's first utility-scale, fault-tolerant quantum computing facility. The site occupies the footprint of a defunct paper mill on Moreton Bay, industrial infrastructure retired, new infrastructure rising. Sounds ceremonial. It is not. This is steel in the ground. A Linde Engineering cryoplant is on order, scheduled for delivery in H2 2027. The company has already opened its Test and Validation Lab at Griffith University in Brisbane, running live cryogenic systems to validate the photonic chips and subsystems that will populate the facility once it opens in 2029. This is not a bet anymore. This is execution.
The capital backing explains why the timeline moved from aspiration to schedule. On April 30, 2024, the Australian and Queensland governments committed approximately $940 million AUD (roughly $620 million USD) specifically for this facility. In September 2025, PsiQuantum closed a $1 billion Series E round co-led by BlackRock, Temasek, and Baillie Gifford, with participation from Nvidia's venture arm, valuing the company at $7 billion. Earlier this year, the company signed a $100 million letter of intent with the U.S. Department of Commerce under the CHIPS and Science Act. That is nearly $2 billion in capital commitments, government and private, moving through a single quantum company in 18 months. IBM and Google have raised more total capital over their quantum lives, but neither raised this much capital this fast for a single facility. The money is real. The commitments are binding. The facility will be built.
What makes Moreton Bay different is not scale alone but architectural bet. PsiQuantum's photonic approach routes particles of light through silicon chips manufactured in conventional semiconductor foundries, then networks the cryogenic cabinets together using standard optical fibre. IBM and Google bet on superconducting qubits, tiny quantum circuits cooled to near absolute zero, isolated in vacuum chambers, each qubit requiring its own control and readout infrastructure. Superconducting is mature; IBM has deployed systems for over a decade. Photonics is faster to manufacture, leverages existing chip fabs, and requires less exotic control hardware, but it has never been deployed at utility scale. PsiQuantum's groundbreaking is the signal that photonics has moved from "interesting research" to "government-backed production competitor." If the facility works, if chips scale, if the cryoplant integrates, if error correction converges toward the theoretical advantage, then photonics becomes the modality that superconducting companies have to defend against, not the other way around.
The site itself matters operationally. Moreton Bay Central sits where the Petrie Paper Mill once operated, existing power infrastructure, water utility connections, industrial zoning, workforce pipeline. A greenfield site would add 18 months to timeline. Using industrial footprints that already exist saves years. Queensland's government understood this and sold the site with regulatory tailwind and infrastructure already staged. The city of Moreton Bay mayor, Peter Flannery, framed it as jobs and manufacturing, which it is, but the real play is that a photonic quantum facility can plausibly be built on an industrial timeline in an industrial location, not in a university lab or a tech park, because it uses standard cryogenic equipment and conventional chip manufacturing. That is the architectural advantage translated into real-world project management.
Two specific markers now determine whether PsiQuantum's bet holds. First: the Linde cryoplant delivery and integration in H2 2027. If that ships and works, the facility is on track. If it slips or fails, the 2029 timeline evaporates and superconducting remains the only deployed modality. Second: the U.S. CHIPS Act $100 million letter of intent needs to convert to a binding award. The LOI is non-binding; the award will likely come with U.S. government oversight, audit rights, and domestic manufacturing requirements. If the CHIPS office funds it, PsiQuantum gets U.S. operational leverage and supply-chain protection. If the LOI lapses, the company stays entirely dependent on Australian and private capital. Watch those two milestones. Everything else is on track.